These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 347790)

  • 1. [RMP and INH plasma levels in comparison to aminotransferase behavior during a tuberculostatic threefold combination therapy].
    Knop P; Kindler U; Austerhoff A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1593-6. PubMed ID: 347790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
    Knop P; Kindler U; Austerhoff A
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1913-5. PubMed ID: 598300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin: a first line tuberculostatic drug. A critical review and appraisal.
    Saerens EJ
    Acta Tuberc Pneumol Belg; 1972; 63(6):516-28. PubMed ID: 4206441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
    Regli J; Ziegler WJ
    Schweiz Rundsch Med Prax; 1974 Jan; 63(2):49-50. PubMed ID: 4212815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver].
    Musch E; Eichelbaum M; Wang JK; von Sassen W; Ochs HR; Castro-Parra M; Dengler HJ
    Med Welt; 1982 Jun; 33(25):911-4. PubMed ID: 7109939
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications, dosage and combinations of the major antitubercular drugs].
    Lebeau B; Rochemaure J
    Rev Prat; 1979 Jun; 29(33):2653-65. PubMed ID: 482818
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
    Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
    Grosset J; Truffot C; Fermanian J; Lecoeur H
    Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].
    Pilheu JA; De Salvo MC; Barcat JA
    Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of tuberculosis in the 1980s.
    Jones FL
    Pa Med; 1983 Feb; 86(2):36-40. PubMed ID: 6682542
    [No Abstract]   [Full Text] [Related]  

  • 14. The combination of rifampicin and other antituberculous agents in chronic murine tuberculosis.
    Kradolfer F; Schnell R
    Chemotherapy; 1971; 16(3):173-82. PubMed ID: 5561406
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Rifampin in the treatment of tuberculosis.
    Grzybowshi S
    Can Med Assoc J; 1974 May; 110(9):1002 passim. PubMed ID: 4823101
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Which treatment for primary tuberculosis?].
    Gallet S; Bellon G
    Pediatrie; 1989; 44(9):699-704. PubMed ID: 2695890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
    Dickinson JM
    Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of rifampicin on the treatment of tuberculosis.
    Bayliss CG
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():140-3. PubMed ID: 4467983
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modern view on drug therapy of tuberculosis].
    Douma J
    Ned Tijdschr Geneeskd; 1972 Oct; 116(41):1864-5. PubMed ID: 4640232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.